Thymosins can enhance body immunity and are mainly used in the treatment of hepatitis and tumors. Thymosins mainly include Thymosin, Thymopentin and Thymosin α1. Thymosin α1 is a high-end thymosin. Clinical trials suggest it may be useful in cystic fibrosis, septic shock, acute respiratory distress syndrome, peritonitis, acute cytomegalovirus infection, TB, severe acute respiratory syndrome, and lung infections in critically ill patients., and for chronic hepatitis B. It also has been studied for possible use in treating cancer (eg with chemotherapy).
This report contains market size and forecasts of Thymosin α1 in global, including the following market information:
Global Thymosin α1 Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Thymosin α1 Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Thymosin α1 companies in 2021 (%)
The global Thymosin α1 market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Freeze-dried Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Thymosin α1 include Abbiotec, SciClone Pharmaceuticals, Shanghai Soho-Yiming Pharmaceuticals, Hainan Zhonghe Pharmaceutical, Hainan Shuangcheng Pharmaceuticals, Hybio Pharmaceutical and Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Thymosin α1 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Thymosin α1 Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Thymosin α1 Market Segment Percentages, by Type, 2021 (%)
Freeze-dried Powder
Injection
Global Thymosin α1 Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Thymosin α1 Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Thymosin α1 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Thymosin α1 Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Thymosin α1 revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Thymosin α1 revenues share in global market, 2021 (%)
Key companies Thymosin α1 sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Thymosin α1 sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbiotec
SciClone Pharmaceuticals
Shanghai Soho-Yiming Pharmaceuticals
Hainan Zhonghe Pharmaceutical
Hainan Shuangcheng Pharmaceuticals
Hybio Pharmaceutical
Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical